October 31, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) --…
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…
CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies,…
BEIJING, Oct. 30, 2025 /PRNewswire/ -- The Annual Conference of Financial Street Forum 2025 kicked off here on Monday, bringing…
New benchmark results confirm the Clarifai Reasoning Engine on Vultr's GPU clusters delivers unprecedented speed, efficiency, and scalability for next-gen AI…
October 27, 2025 16:05 ET | Source: CompoSecure, Inc. SOMERSET, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NYSE:…
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolismRobust…
October 24, 2025 12:00 ET | Source: Flare Therapeutics Inc. FX-909, the first small molecule targeting PPARG to be tested…
October 22, 2025 16:30 ET | Source: CVRx, Inc. MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX)…